• RESEARCH SEMINAR: Prof. Lisa Chasan-Taber, 12.45pm, 4th May 2016

    Prof. Lisa Chasan-Taber Sc.D., University of Massachusetts, Amherst, Massachusetts, USA will present her seminar “Exercise During and after Pregnancy-Opportunities and Challenges to Prevent Health Complications in Mothers and their Babies” on Wednesday, 4th May 2016 at 12.45pm – 2:00pm in PESS Building P1007

    Tea/Coffee & Light Lunch @12.45-1.00

    RSVP by 28th April to: Rhoda.Sohun@ul.ie
    (For catering purposes)

  • UL Professor Kieran Hodnett receives Boyle Higgins Gold Medal

    Professor Kieran Hodnett, UL receiving the Boyle Higgins Gold Medal

    In recognition of his outstanding contribution to chemistry, Professor Kieran Hodnett, a member of the Chemical and Environmental Sciences department (CES) at the University of Limerick and Scientific Director of the Science Foundation Ireland (SFI) funded Synthesis and Solid State Pharmaceutical Centre (SSPC), recently received the 2016 Institute of Chemistry of Ireland Boyle Higgins Gold Medal.

  • Dr Graham Love - HRB Strategy, followed by Q&A - 28 April 2016

    Dr Graham Love Chief Executive, Health Research Board (HRB)

    Dr Graham Love, Chief Executive, Health Research Board (HRB) will be presenting

    HRB Strategy, followed by a Q&A session


    Date: Thursday 28th April 2016, 12.00pm
    Venue: GEMS0016, GEMS Building, UL

    All are welcome to attend

  • HRI Seminar Series: Professor Ivan Perry - 27 April 2016

    Professor Ivan Perry, University College Cork

    The HRI are delighted to welcome Professor Ivan Perry from University College Cork who will open our 2016 seminar series on Wednesday 27th April 2016, 12.45pm, in LERO ROOM T3-013, Tierney Building with his presentation entitled:

    “Obesity: A public health perspective on behaviour change”.

  • Building an Innovation Ecosystem

    Dr Michael Walsh, Technology Enhanced Health Outcomes Theme Leader, HRI

    Technological developments play a vital role in enhancing patient treatments and thus sustain and improve the health of the population. Dr Walsh is working with an interdisciplinary team of national and international collaborators consisting of clinicians, academics and industrialists to assess how existing medical technologies can be advanced and new technologies can be developed to enhance the treatment of vascular diseases.